Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Randomized, Double Blind Multicenter Phase 3 Study of the Efficacy, Safety, and Tolerability of 28 Weeks of Brincidofovir vs Valganciclovir for the Precention of Cytomegalovirus Disease in High Risk Kidney Allograft Recipients (303)
Shah, Malay
(PI)
Surgery
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
7/25/16
→
9/6/16
Funding
Chimerix Incorporated:
$6,052.00
View all
View less